Medical device firm Tandem Diabetes is to trial a new algorithm-based version of its leading insulin pump which can predict future blood glucose levels and automatically adjust insulin levels ...

Receiving FDA clearance would allow Medtronic to pair its pumps with a glucose monitor being developed for the company by ...

Medtronic announced today that it submitted 510(k) applications to the FDA seeking clearance for an interoperable insulin ...

Read more about Deep reinforcement learning could redefine insulin delivery for diabetes patients on Devdiscourse ...

Medtronic (MDT) has submitted 510(k) applications to the FDA seeking clearance for an interoperable pump. FDA clearance of this pump would pave ...

FDA clearance would allow Medtronic to integrate the device with Abbott's continuous glucose monitoring sensor, advancing the companies' partnership.

Medtronic has submitted 510(k) applications to the U.S. Food and Drug Administration seeking clearance for an interoperable pump.

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has submitted 510(k) applications to the U.S. Food and Drug Administration (FDA) seeking clearance for an ...

Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), is an important and evolving form of insulin delivery, which is mainly used for people with type 1 diabetes.

The technology known as Advance-Hybrid Closed-Loop consists of an algorithm on an insulin pump which communicates with the traditional continuous glucose monitoring. The real-time glucose ...

This is also the only AID algorithm that allows users to program ... Additionally, in December 2024, the company’s t:slim X2 ...